← Back to Search

Cryolipolysis

Effects on Cellulite Appearance (EFC Trial)

N/A
Waitlist Available
Research Sponsored by Zeltiq Aesthetics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-month post final data collection
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates the safety and feasibility of using CoolSculpting to improve the appearance of cellulite on the thighs. CoolSculpting is a non-surgical method that freezes and kills fat cells, which are then naturally removed by the body. The technique used in CoolSculpting initially received FDA clearance for fat reduction in the abdomen and flanks and has since been approved for use on other areas including the thighs.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-month post final data collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and one-month post final data collection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
visible changes in the treated areas on Photos
Secondary study objectives
AE's

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fat ReductionExperimental Treatment1 Intervention
The treatments are designed to see if the appearance of cellulite can be reduced on the outer thigh with a new applicator design.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The ZELTIQ System
2019
N/A
~220

Find a Location

Who is running the clinical trial?

Zeltiq AestheticsLead Sponsor
40 Previous Clinical Trials
1,788 Total Patients Enrolled
Lori Brandt, BSNStudy DirectorZeltiq Aesthetics
1 Previous Clinical Trials
60 Total Patients Enrolled
~12 spots leftby Dec 2025